Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update

Roni P. Dodiuk-Gad, Wen Hung Chung, Laurence Valeyrie-Allanore, Neil H. Shear*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

142 Scopus citations

Abstract

Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening mucocutaneous reactions, predominantly drug induced. The mortality rates for SJS and TEN are as high as 30 %, and short- and long-term morbidities are very common. SJS/TEN is one of the few dermatological diseases that constitute a true medical emergency. Early recognition and prompt and appropriate management can be lifesaving. In recent years, our understanding of the pathogenesis, clinical presentation, and management of SJS/TEN has improved. Nevertheless, in 2015, there are still no internationally accepted management guidelines. This review summarizes up-to-date insights on SJS/TEN and describes a protocol for assessment and treatment. We hope these suggested guidelines serve as a practical clinical tool in the management of SJS/TEN. The classic manifestation of SJS/TEN consists of initial “flu-like” symptoms (malaise, fever, anorexia) in the prodromal phase, followed by cutaneous and mucous membrane (ocular, oral, and genital) inflammation and pain, and other systemic involvement. Symptoms usually begin 4–28 days after the onset of drug intake. Treatment is multidisciplinary and includes identification and withdrawal of the culprit drug, transfer to a specialist unit, supportive care, medical treatment, communication, and provision of appropriate information and emotional support.

Original languageEnglish
Pages (from-to)475-493
Number of pages19
JournalAmerican Journal of Clinical Dermatology
Volume16
Issue number6
DOIs
StatePublished - 01 12 2015

Bibliographical note

Publisher Copyright:
© 2015, Springer International Publishing Switzerland.

Fingerprint

Dive into the research topics of 'Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update'. Together they form a unique fingerprint.

Cite this